https://www.avient.com/sites/default/files/2021-12/avient-sarl-hungary-branch-register-extract-2021-12-07.pdf
Foreign name(s), foreign abbreviated name(s) of the company 4/2.
Data on the senior officer(s) and person(s) entitled to representation 13/1.
https://www.avient.com/sites/default/files/2020-08/2020-composite-springs-product-selection-install-guide.pdf
TYPICAL PROPERTIES Sample thickness 0.25 in/6.35mm TEMPERATURE FLEXURAL STRENGTH ASTM D790 FLEXURAL MODULUS ASTM D790 °F °C ksi MPa msi GPa -60 -51 173 1193 5.00 34.48 70 21 155 1069 5.11 35.23 160 71 138 952 5.04 34.75 250 121 110 758 4.70 32.41 300 149 78 538 4.22 29.10 -60 -51 176 1211 5.64 38.92 70 21 143 989 5.36 36.98 160 71 120 824 5.57 38.41 250 121 61 423 4.82 33.24 -60 -51 163 1125 4.19 28.88 70 21 120 824 3.85 26.51 160 71 86 595 3.83 26.44 250 121 40 274 3.19 22.00 Gl as s/ Ep ox y H ig h Te m p Ep ox y/ Gl as s Gl as s/ Vi ny l E st er MECHANICAL PERFORMANCE TESTING NOTES Springs were fatigue tested at 4 hz in a cantilevered loading.
TEMPERATURE, MPa Temperature (C) Fl ex ur al S tr en gt h (M Pa ) Fl ex ur al M od ul us (G Pa ) 20 25 30 35 40 Glass/Epoxy High Temp Glass/Vinyl ester 1409040-10-60 0 300 600 900 1200 1500 Glass/Epoxy High Temp Epoxy/Glass Glass/Vinyl Ester 1901409040-10-60 200 400 600 800 1000 1200 14801280108088068048028080 FLEXURAL MODULUS VS.
TEMPERATURE, GPa Temperature (C) 20 25 30 35 40 Glass/Epoxy High Temp Glass/Vinyl ester 1409040-10-60 0 300 600 900 1200 1500 Glass/Epoxy High Temp Epoxy/Glass Glass/Vinyl Ester 1901409040-10-60 200 400 600 800 1000 1200 14801280108088068048028080 FLEXURAL FATIGUE STRENGTH, MPa Cycles to Failure (in thousands) Fl ex ur al F at iq ue S tr en gt h (M Pa ) INSTALLATION INSTRUCTIONS Proper installation of composite springs from Avient is essential to achieve optimal performance and maximum service life.
https://www.avient.com/sites/default/files/resources/TRA%2520-%25202016%2520Plan%2520Summary.pdf
Toxic Reduction Options for Implementation Description of the toxic reduction option(s) to be implemented Is there a statement that no option will be implemented?
* Yes, we are not implementing If you answered “No” to this question, please add the option(s) under the appropriate Toxic Substance Reduction Categories (e.g.
If you answered “Yes” please select the appropriate reason(s) in the picklist below for why no option was implemented for this substance at your facility.
https://www.avient.com/sites/default/files/resources/PolyOne%25202012%2520Annual%2520Report.pdf
S/ STEPHEN D.
s/ Stephen D.
s/ Richard J.
https://www.avient.com/sites/default/files/2020-10/neu-quality-commitment.pdf
Location(s) North Haven, CT As a valued customer (“Customer”) of NEU Specialty Materials, LLC (“NEU”), NEU is communicating this Quality Commitment to communicate the quality parameters, expectations and risk surrounding quality matters for the products NEU supplies.
This document is property of Avient Corporation and may not be reproduced or communicated to third parties without authorization. 5.5 Regulatory Documents: A document referencing the then-current regulatory status of the applicable product(s) at the time of shipment.
Upon notification from the NEU supplier, NEU will notify the Customer of the effect on the manufacture of the compound(s) (such as raw material availability, vendor name changes, vendor manufacturing location, and vendor nomenclature). 9.0 CUSTOMER FEEDBACK 9.1 NEU will use commercially reasonable efforts to (i) acknowledge receipt of Customer complaints within one business day; (ii) conduct an investigation and communicate a resolution to Customer within 30 days after receipt of the complaint.
https://www.avient.com/sites/default/files/2021-01/w-9-clariant-plastics-coatings-usa-llc-july-20201.pdf
S ee S p ec ifi c In st ru ct io ns o n p ag e 3. 1 Name (as shown on your income tax return).
Enter the tax classification (C=C corporation, S=S corporation, P=Partnership) ▶ Note: Check the appropriate box in the line above for the tax classification of the single-member owner.
P= Partnership; C= C corporation; or S= S corporation) • Partnership Partnership • Trust/estate Trust/estate Line 4, Exemptions If you are exempt from backup withholding and/or FATCA reporting, enter in the appropriate space on line 4 any code(s) that may apply to you.
https://www.avient.com/sites/default/files/2021-04/avient-q4-earnings-and-2021-outlook-website.pdf
Microsoft PowerPoint - Avient Q4 Earnings and 2021 Outlook PRINT AVIENT CORPORATION F O U R T H Q U A R T E R 2 0 2 0 R E S U L T S A N D 2 0 2 1 F I N A N C I A L G U I D A N C E (NYSE: AVNT) F E B R U A R Y 9 , 2 0 2 1 DISCLAIMER 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
D is t. ) R P M P P G K W R F U L A V Y G C P IF F F M C H X L H U N E M N F O E E C L K R A S C L A S H C E G R A A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of February 5, 2021 Avient reflects 2021 estimated revenue of $4,100M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 24 Avient reflects 2021 estimated EBITDA of $510M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 9.5 21.1 13.2 13.2 12.0 12.0 9.7 25.2 23.1 14.7 13.5 12.9 11.0 11.0 11.0 10.2 9.6 9.3 9.3 9.1 8.6 8.3 A vi en t K W R A V Y R P M G C P P P G F U L A L B E C L H X L IF F F M C G R A B N R F O E A S H C E S C L U N V R E M N H U N K R A Median: 11.0xMedian: 12.6x SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/resources/Novel_Thermoplastic_elastomers_for_overmolding_applications.pdf
Surface energy match of various thermoplastic elastomers with rigid thermoplastics Engineering Plastics Polyamide 6,6 ABS Polycarbonate Acrylic Polystyrene Polypropylene Polyethylene Elastomer s COPA TPU COPE S-TPE TPV mPE Surface Energy (mN/m) 46 43 40 37 34 31 28 Engineering Plastics Polyamide 6,6 ABS Polycarbonate Acrylic Polystyrene Polypropylene Polyethylene Elastomer s COPA TPU COPE S-TPE TPV mPE Surface Energy (mN/m) 46 43 40 37 34 31 28 Figure 2.
OM6240 tensile properties: initial and final after 1 week at 70°C 2.8 1.8 2.6 2.8 1.8 2.6 0 0.5 1 1.5 2 2.5 3 Tensile Strength 100% Modulus 300% Modulus Pa sc al s Initial Final Figure 8: Physical property retention of Versaflex OM 6240 after 1week at 70°C.
OM6258 tensile properties after 1 week at 70°C 2.9 2.8 2.1 3 3.2 2.1 0 0.5 1 1.5 2 2.5 3 3.5 Tensile Strength 100% Modulus 300% Modulus Pa sc al s Initial Final Figure 9: Physical Property retention of OM 6258 after 1 week at 70°C.
https://www.avient.com/sites/default/files/resources/POL%2520BofA%2520Basic%2520Materials%2520IR%2520Presentation%2520w%2520non-GAAP%252012%252011%25202013.pdf
Use of Non-GAAP Measures Page 3 -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% PolyOne S&P 500 All time high of $34.47 December 9th, 2013 • 16 consecutive quarters of double digit EPS growth • 42% CAGR adjusted EPS expansion 2006-2012 • YTD stock price has increased 63% versus 27% growth in the S&P • More than six fold increase in market cap: $0.5b $3.3b Strategy and Execution Drive Results Page 4 The World’s Premier Provider of Specialized Polymer Materials, Services & Solutions Four Pillar Strategy Page 5 PP&S 15% Specialty 60% Distribution 25% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010* 2011* 2012* 2015 Target Ad ju st ed E ar ni ng s P er S ha re Appliance 6% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 4% Consumer 9% Packaging 18% Industrial 10% Misc. 5% HealthCare 9% Transportation 16% Textiles 1% United States 70% Europe 14% Canada 8% Asia 5% Latin America 3% 2012 Revenues: $4.0 Billion* End Markets* 2012 Revenues: $4.0 Billion* EPS Page 6 * Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes discontinued operations PolyOne At A Glance * Restated to exclude discontinued operations Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 63% 65- 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 YTD 2013 2015 % o f O pe ra tin g In co m e* JV's PP&S Distribution Specialty Specialty OI $5M $46M $87M $153M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 7 2006 YTD 2013 2015 Where we were Where we are Organic Consolidated Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 12.8% 12.8% 12 – 16% Global Specialty Engineered Materials 1.1% 10.8% 8.9% 12 – 16% Designed Structures & Solutions — — 5.0% 8 – 10% Performance Products & Solutions 5.5% 8.0% 8.2% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 63% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 28% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 8 *Percentage of Specialty Platform revenue from products introduced in last five years 19.5% 44.0% 2006 Q3 2013 $20.3 $46.6 2006 TTM Q3'13 14.3% 31.0% 2006 Q3 2013 Research & Development Spending Specialty Platform Vitality Index Progression* Innovation Drives Earnings Growth ($ millions) Specialty Platform Gross Margin % Page 9 We are Experts in Polymer Science and Formulation Polymer Science Formulation Chemistry Processing Inputs Base Resins Additives Modifiers Colorants Specialized Polymer Materials, Services, and Solutions Expertise Satisfied Consumers PolyOne Customer Innovative Products & Services Marketplace Demands Performance Requirements Value Drivers Page 10 Positioned for Strong Growth 2015 Target Rev: $5B Adj.
EPS: $2.50 Assumptions • Mid single digit revenue CAGR • Operating margins in mid-range of 2015 targets • No global recession • No investment in incremental PP&S capacity • Housing starts at 85% of 50 year norm by 2015 • Remain comfortably below 3X Net Debt / EBITDA Page 11 2012 Rev: $2.9B Adj.
Platform sales and operating income (OI) 2006Y* YTD 2013 Organic’ Acquisitions** YTD 2013’ Consolidated Global Specialty Engineered Materials Sales $ 345.3 $ 427.2 $ 113.6 $ 540.8 Global Color, Additives and Inks Sales 531.8 608.0 45.7 653.7 Designed Structures and Solutions Sales - - 428.2 428.2 Specialty Platform Sales $ 877.1 $ 1,035.2 $ 587.5 1,622.7 Performance Products and Solutions Sales 1,166.2 473.6 39.2 512.8 PolyOne Distribution Sales 732.8 818.1 - 818.1 Corporate and eliminations (153.7) (106.0) - (106.0) Total Sales $ 2,622.4 $ 2,220.9 $ 626.7 $ 2,847.6 Global Specialty Engineered Materials OI $ 3.9 $ 46.1 $ 2.1 $ 48.2 Global Color, Additives and Inks OI 8.9 78.0 5.4 83.4 Designed Structures & Solutions OI - - 21.4 21.4 Specialty Platform OI $ 12.8 $ 124.1 $ 28.9 $ 153.0 Performance Products and Solutions OI 64.2 38.1 3.7 41.8 PolyOne Distribution OI 19.2 49.7 - 49.7 Sunbelt Joint Venture OI 102.9 - - - Corporate and eliminations (4.6) (39.5) - (39.5) Special items in OI 39.1 (22.2) - (22.2) Operating income GAAP $ 233.6 $ 150.2 $ 32.6 $ 182.8 Sunbelt equity income (107.0) - - - Special items in OI (39.1) 22.2 - 22.2 Operating income adjusted $ 87.5 $ 172.4 $ 32.6 $ 205.0 Global Specialty Engineered Materials - OI % of sales 1.1% 10.8% 1.8% 8.9% Global Color, Additives and Inks - OI % of sales 1.7% 12.8% 11.8% 12.8% Designed Structures & Solutions - OI % of sales - - 5.0% 5.0% Specialty platform OI - % of sales 1.5% 12.0% 5.0% 9.4% PP&S operating OI - % of sales 5.5% 8.0% 9.4% 8.2% Distribution OI - % of sales 2.6% 6.1% - 6.1% PolyOne OI adjusted - % of sales 3.3% 7.8% 5.2% 7.2% * Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment. ** Spartech and Glasforms results for the nine months ended September 30, 2013.
https://www.avient.com/sites/default/files/2024-03/AVNT February IR Presentation_w_Non-GAAP Recs_v2.pdf
Avient corporation first quarter 2023 results AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) F E B R UA RY 2 0 2 4 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
Continue fostering our Great Place to Work® culture Strategic Objectives Long Term Growth Rates Growth Drivers $340 $455 $790 $1,135 2016 2018 2020 2023 $51 $84 $212 $645 2016 2018 2020 2023 $108 $113 $231 $230 2016 2018 2020 2023 $265 $358 $726 $725 2016 2018 2020 2023 8-12% 8-10% 8-10% 5% Sustainable Solutions Composites Healthcare Asia/Emerging Regions Profitable Growth Great Place to Work 5.4% 10.9% 16.0% 2006 2014 2023 EBITDA Margins $0.14 $1.93 $2.36 2006 2014 2023 Adjusted EPS TOP-TIER SUSTAINABILITY PERFORMANCE AND RECOGNITION Industry Sustainability Standards ESG Ratings Performance 1 2 4 87th 94th percentile 5 Avient CDP Score: A- FE BRUARY 14 , 2024 W E BCAS T P RE S E N TAT I O N DR.
ASHISH KHANDPUR PRESIDENT & CEO 7 8 PORTFOLIO TRANSFORMATION 8 7% 46% 66% 87% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2015 2020 2023 % o f A dj us te d EB IT D A Commodity JVs Distribution Performance Products & Solutions Specialty Businesses Adjusted EBITDA from Specialty Applications SUSTAINABILITY AS A GROWTH DRIVER 9 LONG-TERM REVENUE GROWTH DRIVERS Sustainable Solutions Composites, Healthcare, Asia / LATAM Overlap Other 60%+ Key Growth Drivers Total Company Revenue Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Composites 8–10% Healthcare 8–10% Asia / LATAM 5% Other 0–2% Avient 6% END MARKET OBSERVATIONS (% OF COMPANY SALES) ENERGY 5% DEFENSE 7% TELECOMMUNICATIONS 4% HEALTHCARE 7% 10 TRANSPORTATION 10% INDUSTRIAL 16% BUILDING & CONSTRUCTION 9% CONSUMER 19% PACKAGING 23% 11 REGIONAL OBSERVATIONS (% OF COMPANY SALES) 11 US & Canada Latin America EMEA Asia 41% 36% 18% 5% Q 4 2023 RE S U LT S Q4 2023 PERFORMANCE VS.